H.R. 4605 — End Prescription Drug Ads Now Act

This section prohibits direct-to-consumer advertising of prescription drugs approved under section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 352) or biologics licensed under section 351 of the Public Health Service Act (42 U.S.C. 262) by deeming such drugs misbranded if the application holder or licensee has conducted such advertising within the prior 30 days. The prohibition, which covers advertising via television, radio, print media, digital platforms, or social media, takes effect 30 days after enactment and applies to all such drugs regardless of approval or licensure date.